The transient tumor associated hypoglycemia stimulates the secretion of growth hormone which further enhances tumor growth stimulating indirectly further uptake of glucose by tumor and other tissues and thus leading to further hypoglycemia. This evidence concerns the gene GH1 and neoplasm.